[
  {
    "title": "毕得医药(688073.SH)：拟开展不超6000万美元的外汇套期保值业务",
    "href": "http://stock.jrj.com.cn/2022/11/10181337128382.shtml",
    "datetime": "2022-11-10 18:13:54",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073.SH)：拟使用不超5亿元自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/11/10181237128384.shtml",
    "datetime": "2022-11-10 18:12:52",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073.SH)：第三季度净利增65.44%至3884.397万元",
    "href": "http://stock.jrj.com.cn/2022/10/27193637090897.shtml",
    "datetime": "2022-10-27 19:36:39",
    "code": "688073"
  },
  {
    "title": "毕得医药2022年前三季度预计净利9802万同比增加47% 科学试剂细分市场需求旺盛",
    "href": "http://stock.jrj.com.cn/2022/10/17213237061957.shtml",
    "datetime": "2022-10-17 21:32:18",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073.SH)前三季度净利润预增46.95%",
    "href": "http://stock.jrj.com.cn/2022/10/17184837061385.shtml",
    "datetime": "2022-10-17 18:48:46",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073.SH)：将于10月11日在科创板上市",
    "href": "http://stock.jrj.com.cn/2022/10/09153537041522.shtml",
    "datetime": "2022-10-09 15:35:55",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073)：披露网上发行中签结果",
    "href": "http://stock.jrj.com.cn/2022/09/27091237023673.shtml",
    "datetime": "2022-09-27 09:12:10",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073)：网上发行中签率为 0.03846846%",
    "href": "http://stock.jrj.com.cn/2022/09/26091037020242.shtml",
    "datetime": "2022-09-26 09:10:53",
    "code": "688073"
  },
  {
    "title": "IPO打新观察：毕得医药每股发行价88元，华创证券报出125元最高价",
    "href": "http://stock.jrj.com.cn/ipo/2022/09/22194637015093.shtml",
    "datetime": "2022-09-22 19:46:21",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073)：发行价格确定88元/股，发行日期2022年9月23日（T日）",
    "href": "http://stock.jrj.com.cn/2022/09/22091537013064.shtml",
    "datetime": "2022-09-22 09:15:05",
    "code": "688073"
  },
  {
    "title": "毕得医药(688073)：首发1622.91万股，询价日期为2022年9月20日周二",
    "href": "http://stock.jrj.com.cn/2022/09/15091136996077.shtml",
    "datetime": "2022-09-15 09:11:29",
    "code": "688073"
  },
  {
    "title": "新进展！毕得医药闯关科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2022/06/07102136708160.shtml",
    "datetime": "2022-06-07 10:21:12",
    "code": "688073"
  },
  {
    "title": "科创板上市委：富创精密、毕得医药首发获通过",
    "href": "http://stock.jrj.com.cn/2022/05/05170836570238.shtml",
    "datetime": "2022-05-05 17:08:59",
    "code": "688073"
  },
  {
    "title": "富创精密、毕得医药5月5日迎来科创板IPO上会审核",
    "href": "http://stock.jrj.com.cn/2022/04/26114336474043.shtml",
    "datetime": "2022-04-26 11:43:41",
    "code": "688073"
  },
  {
    "title": "三轮问询“存货”问题被独提，毕得医药科创板IPO这样答复",
    "href": "http://stock.jrj.com.cn/2022/04/21094636416311.shtml",
    "datetime": "2022-04-21 09:46:19",
    "code": "688073"
  },
  {
    "title": "知识产权侵权风险及业务合规性几何？毕得医药科创板二轮问询这样解答",
    "href": "http://stock.jrj.com.cn/2022/04/06090536260760.shtml",
    "datetime": "2022-04-06 09:05:21",
    "code": "688073"
  },
  {
    "title": "毕得医药首答科创板问询，侵犯第三方专利权风险被关注",
    "href": "http://stock.jrj.com.cn/2022/02/18090134384509.shtml",
    "datetime": "2022-02-18 09:01:39",
    "code": "688073"
  },
  {
    "title": "深创投等加持赴考上市，毕得医药科创板IPO获问询",
    "href": "http://stock.jrj.com.cn/2021/12/27094934068940.shtml",
    "datetime": "2021-12-27 09:49:09",
    "code": "688073"
  },
  {
    "title": "深创投等投资机构加持，姐弟携手带着毕得医药赶考科创板IPO",
    "href": "http://stock.jrj.com.cn/2021/12/02090833953889.shtml",
    "datetime": "2021-12-02 09:08:21",
    "code": "688073"
  },
  {
    "title": "毕得医药启动上市辅导：签有具备GMP资质的合作工厂",
    "href": "http://stock.jrj.com.cn/2021/01/12181431677564.shtml",
    "datetime": "2021-01-12 18:14:05",
    "code": "688073"
  },
  {
    "title": "毕得医药拟登陆A股，已聘请海通证券为其上市“护航”",
    "href": "http://stock.jrj.com.cn/2021/01/07154031648148.shtml",
    "datetime": "2021-01-07 15:40:24",
    "code": "688073"
  }
]